AAS
ANIX icon

Avantax Advisory Services’s Anixa Biosciences ANIX Stock Holding History

Avantax Advisory Services’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-53,150
Closed -$129K – 949
2020
Q3 		$129K Buy
+53,150
New +$137K ﹤0.01% 1281

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Avantax Advisory Services's ANIX Position: Q4 2020 in Review

Avantax Advisory Services sold out of Anixa Biosciences (ANIX) in Q4 2020, closing a stake of 53,150 shares — an estimated $129K sold.

Avantax Advisory Services first reported a position in ANIX in Q3 2020 and held it in 1 quarter. The position peaked at $129K in Q3 2020. 22 funds tracked by Wall St. Rank hold ANIX as of Q4 2020.

  • Avantax Advisory Services reported no remaining Anixa Biosciences position as of Q4 2020 after selling out during the quarter.
  • Avantax Advisory Services sold 53,150 Anixa Biosciences shares in Q4 2020, an estimated $129K.
  • Avantax Advisory Services first reported a position in Anixa Biosciences in Q3 2020 and held it in 1 quarter.
  • Avantax Advisory Services's Anixa Biosciences position peaked at $129K in Q3 2020.
  • 22 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2020.

Based on Avantax Advisory Services's 13F filing for Q4 2020, filed 22 Jan 2021.